查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571822

美國胃腸病門診手術中心市場規模、佔有率和趨勢分析報告：按所有權和細分市場預測，2024-2030 年

U.S. Gastroenterology Ambulatory Surgery Centers Market Size, Share & Trends Analysis Report By Ownership (Hospital-affiliated, Freestanding, Corporation-owned), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

美國胃腸病門診手術中心市場成長與趨勢

Grand View Research 的最新報告顯示，到 2030 年，美國胃腸病門診手術中心市場規模預計將達到 97.8 億美元。

預計2024年至2030年複合年成長率為6.8%。這種成長得益於門診手術中心提供的成本效率、患者治療效果的改善以及患者的便利性。此外，消化器官系統疾病盛行率上升和老年人口不斷增加等因素預計將支持成長。

建立和維護醫院及其他醫療保健設施是資本集中的。此外，由於住院費用較高，越來越多的患者更喜歡門診設施而不是門診就診。近年來，美國門診手術中心（ASC）的數量迅速增加，以滿足對替代手術設施不斷成長的需求。目前美國有超過 9,280 個 ASC，集中在加利福尼亞州、佛羅裡達州和德克薩斯。

其他細分市場包括由醫師-醫院、醫師-醫院-企業和醫師-企業-胃腸病學等各種合資企業擁有的ASC。由於更好的患者治療效果、更高的生產力和所有權關係，聯合資助的醫生-醫院 ASC 越來越受歡迎。

聯盟和收購的增加是預計推動市場成長的主要因素。 2019 年 2 月，SurgCenter Development 與外科合作夥伴達成協議，開發一個新的門診手術中心。

服務供應商的主要產業參與者包括Envision Healthcare Corporation、Tenet Healthcare Corporation、Surgery Partners、Community Health Systems, Inc. (CHS)、Universal Health Service (UHS)、Hospital Corporation of America (HCA) 和Surgery Care Affiliates (SCA )。

美國胃腸病門診手術中心市場報告亮點：

  • 由於對臨床環境的最大程度的專業控制、高盈利以及為患者提供的護理質量，獨立擁有的細分市場在 2023 年佔據了最高的市場佔有率。
  • 市場成長的推動因素是政府高支出開拓門診手術中心以降低治療成本並提高可及性，以及改善在 ASC 進行的手術的報銷政策。
  • 預計未來幾年企業所有權將以 5.4% 的複合年成長率成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國胃腸病門診手術中心市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國胃腸病門診手術中心市場分析工具
    • 波特的分析
    • PESTEL分析

第4章美國胃腸病門診手術中心市場：所有權估計和趨勢分析

  • 細分儀表板
  • 美國胃腸病門診手術中心市場：2023 年和 2030 年所有權變更分析
  • 醫院相關
  • 自主型
  • 企業所有權
  • 其他

第5章競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • TH Medical.
    • GE Healthcare
    • Universal Health Services, Inc.
    • Covenant Physician Partners
    • Regent Surgery
    • Cardinal Health.
    • Boston Scientific Corporation
    • Olympus Corporation
    • Koninklijke Philips NV
    • Cook Medical
簡介目錄
Product Code: GVR-3-68038-928-9

U.S. Gastroenterology Ambulatory Surgery Centers Market Growth & Trends:

The U.S. gastroenterology ambulatory surgery center market size is anticipated to reach USD 9.78 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2024 to 2030. The growth can be attributed to cost-efficiency, improved patient outcomes, and patient convenience provided by the ambulatory surgery centers. In addition, factors such as rising prevalence of digestive diseases and growing geriatric population are expected to fuel the growth.

Establishment and maintenance of hospitals and other healthcare settings are capital-intensive. In addition, high cost of hospitalization associated with inpatient admission has led to increased patient preference for outpatient facilities over hospital visits. The number of ambulatory surgery centers (ASCs) in U.S. has witnessed a surge in the last few years in order to fulfill the growing demand for alternate surgical facilities. Currently, there are more than 9,280 ASCs in U.S. with highest concentration in California, Florida, and Texas.

The other segment includes ASCs owned by various joint ventures such as physician-hospital, physician-hospital-corporate, and physician-corporate gastroenterology. The physician-hospital joint-venture ASCs are gaining traction due to better patient outcomes, enhanced productivity, and ownership interest.

The rising number of partnerships and acquisitions is a key factor expected to drive the growth of the market. In February 2019, SurgCenter Development entered into an agreement with Surgery Partners to develop new ambulatory surgery centers.

Key industry participants among the service provider include Envision Healthcare Corporation; Tenet Healthcare Corporation; Surgery Partners; Community Health Systems, Inc. (CHS); Universal Health Service (UHS); Hospital Corporation of America (HCA); Surgery Care Affiliates (SCA); SurgCenter Development; Covenant Surgical Partners; and Regent Surgical Health.

U.S. Gastroenterology Ambulatory Surgery Centers Market Report Highlights:

  • The freestanding ownership segment accounted for the highest market share in 2023 owing to maximum professional control over clinical environment, high profitability, and quality of care delivered to patients.
  • High government expenditure for the development of ambulatory surgery centers to reduce treatment costs and increase accessibility along with better reimbursement policies for procedures performed at ASC are driving the market growth.
  • Corporation-owned ownership is expected to grow at a CAGR of 5.4% over the projected years.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Gastroenterology Ambulatory Surgery Centers Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. Gastroenterology Ambulatory Surgery Centers Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. Gastroenterology Ambulatory Surgery Centers Market: Ownership Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Gastroenterology Ambulatory Surgery Centers Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Hospital-affiliated
    • 4.3.1. Hospital-affiliated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Freestanding
    • 4.4.1. Freestanding Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Corporation-owned
    • 4.5.1. Corporation-owned Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis by Key Market Participants
  • 5.2. Company Categorization
  • 5.3. Company Heat Map Analysis
  • 5.4. Company Profiles
    • 5.4.1. TH Medical.
      • 5.4.1.1. Participant's Overview
      • 5.4.1.2. Financial Performance
      • 5.4.1.3. Product Benchmarking
      • 5.4.1.4. Recent Developments/ Strategic Initiatives
    • 5.4.2. GE Healthcare
      • 5.4.2.1. Participant's Overview
      • 5.4.2.2. Financial Performance
      • 5.4.2.3. Product Benchmarking
      • 5.4.2.4. Recent Developments/ Strategic Initiatives
    • 5.4.3. Universal Health Services, Inc.
      • 5.4.3.1. Participant's Overview
      • 5.4.3.2. Financial Performance
      • 5.4.3.3. Product Benchmarking
      • 5.4.3.4. Recent Developments/ Strategic Initiatives
    • 5.4.4. Covenant Physician Partners
      • 5.4.4.1. Participant's Overview
      • 5.4.4.2. Financial Performance
      • 5.4.4.3. Product Benchmarking
      • 5.4.4.4. Recent Developments/ Strategic Initiatives
    • 5.4.5. Regent Surgery
      • 5.4.5.1. Participant's Overview
      • 5.4.5.2. Financial Performance
      • 5.4.5.3. Product Benchmarking
      • 5.4.5.4. Recent Developments/ Strategic Initiatives
    • 5.4.6. Cardinal Health.
      • 5.4.6.1. Participant's Overview
      • 5.4.6.2. Financial Performance
      • 5.4.6.3. Product Benchmarking
      • 5.4.6.4. Recent Developments/ Strategic Initiatives
    • 5.4.7. Boston Scientific Corporation
      • 5.4.7.1. Participant's Overview
      • 5.4.7.2. Financial Performance
      • 5.4.7.3. Product Benchmarking
      • 5.4.7.4. Recent Developments/ Strategic Initiatives
    • 5.4.8. Olympus Corporation
      • 5.4.8.1. Participant's Overview
      • 5.4.8.2. Financial Performance
      • 5.4.8.3. Product Benchmarking
      • 5.4.8.4. Recent Developments/ Strategic Initiatives
    • 5.4.9. Koninklijke Philips NV
      • 5.4.9.1. Participant's Overview
      • 5.4.9.2. Financial Performance
      • 5.4.9.3. Product Benchmarking
      • 5.4.9.4. Recent Developments/ Strategic Initiatives
    • 5.4.10. Cook Medical
      • 5.4.10.1. Participant's Overview
      • 5.4.10.2. Financial Performance
      • 5.4.10.3. Product Benchmarking
      • 5.4.10.4. Recent Developments/ Strategic Initiatives